Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypothermic Oxygenated Perfusion To Reduce Tumour Recurrence After Liver Transplantation In Patients With Hepatocarcinoma

NCT05876052 is registered in ClinicalTrials.gov with University of Bologna as lead sponsor.

NCT NCT05876052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05876052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypothermic Oxygenated Perfusion To Reduce Tumour Recurrence After Liver Transplantation In Patients With Hepatocarcinoma
Lead sponsor
University of Bologna
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2023
Completion date
May 31, 2025
Enrollment
192 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ex-vivo hypothermic perfusion, hepatocellular carcinoma, liver cancer, liver transplantation, tumor recurrence